Search research articles
Contact Us
Filters
Showing results (1-10 of 222) with videos related to
Page
of 23
Sort By:
BMC Cancer
|
December 2, 2011
Ten years of progress in radiation oncology
Dirk Vordermark
BMC Medicine
|
July 14, 2010
Hypoxia-specific targets in cancer therapy: role of splice variants
Dirk Vordermark
Radiation Oncology (London, England)
|
June 5, 2020
Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups
Dirk Vordermark
Oncology Research and Treatment
|
September 12, 2016
Radiotherapy of Cervical Cancer
Dirk Vordermark
Oncology Letters
|
August 10, 2017
Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy
Claudia Bitterlich, Dirk Vordermark
Current Opinion in Oncology
|
June 25, 2019
Adjuvant treatment for endometrial cancer
Günter Emons, Dirk Vordermark
Acta Dermato-Venereologica
|
January 31, 2018
Outcome of Combined Treatment of Surgery and Adjuvant Radiotherapy in Merkel Cell Carcinoma
Eckhard Fiedler, Dirk Vordermark
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 28, 2023
The role of radiotherapy in the updated German S2k guideline for management of Merkel cell carcinoma
Dirk Vordermark, Ulrike Höller
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2003
Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies
Dirk Vordermark, J Martin Brown
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
June 20, 2016
Hypoxia as a Biomarker and for Personalized Radiation Oncology
Dirk Vordermark, Michael R Horsman
Page
of 23
Search research articles
Search
Showing results (1-10 of 222) with videos related to
Sort By:
Page
of 23
BMC Cancer
|
December 2, 2011
Ten years of progress in radiation oncology
Dirk Vordermark
BMC Medicine
|
July 14, 2010
Hypoxia-specific targets in cancer therapy: role of splice variants
Dirk Vordermark
Radiation Oncology (London, England)
|
June 5, 2020
Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups
Dirk Vordermark
Oncology Research and Treatment
|
September 12, 2016
Radiotherapy of Cervical Cancer
Dirk Vordermark
Oncology Letters
|
August 10, 2017
Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy
Claudia Bitterlich, Dirk Vordermark
Current Opinion in Oncology
|
June 25, 2019
Adjuvant treatment for endometrial cancer
Günter Emons, Dirk Vordermark
Acta Dermato-Venereologica
|
January 31, 2018
Outcome of Combined Treatment of Surgery and Adjuvant Radiotherapy in Merkel Cell Carcinoma
Eckhard Fiedler, Dirk Vordermark
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 28, 2023
The role of radiotherapy in the updated German S2k guideline for management of Merkel cell carcinoma
Dirk Vordermark, Ulrike Höller
International Journal of Radiation Oncology, Biology, Physics
|
June 28, 2003
Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies
Dirk Vordermark, J Martin Brown
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
June 20, 2016
Hypoxia as a Biomarker and for Personalized Radiation Oncology
Dirk Vordermark, Michael R Horsman
Page
of 23